Institute of Nano Science & Technology, Punjab

Harnessing Nanoscience to
Heal the Brain and
Defeat Cancer

The NeuroNanoMed Laboratory engineers biomolecular nanostructures — built from peptides, proteins, and amino acids — to cross the blood–brain barrier, treat glioblastoma, Alzheimer's disease, stroke, and advance cancer nanotherapeutics.

Explore Research → Join the Lab
Dr. Jiban Jyoti Panda
Dr. Jiban Jyoti Panda
Scientist E · Principal Investigator
Institute of Nano Science and Technology (INST), Mohali
74+ Publications
30+ Awards
15+ Years Research
Principal Investigator

About Dr. Jiban Jyoti Panda

Dr. Jiban Jyoti Panda

Scientist E · PI
Institute of Nano Science & Technology (INST)
Sector-81, Mohali, Punjab – 140306
W Wikipedia Profile 🔗 Current Lab Website @ Email 📄 74+ Peer-reviewed Papers 🏆 30+ Awards & Honors

Biography

Dr. Jiban Jyoti Panda is an eminent Indian scientist at the forefront of nano-biotechnology and neuro-nanomedicine. Currently serving as Scientist E at the Institute of Nano Science and Technology (INST), Mohali, she leads one of India's most innovative groups working at the intersection of nanoscience, neuroscience, and biomedicine.

Her research is distinguished by the design of biocompatible, multi-functional nanostructures derived from peptides, proteins and amino acids for targeted delivery across the blood–brain barrier and blood–retinal barrier.

Recognized globally with honors including the UNESCO-L'Oréal Fellowship, DBT Har Gobind Khorana Award, and ICMR-DHR Fellowship.

Education

Ph.D., Biotechnology
ICGEB, New Delhi
2012
M.Sc., Biotechnology
Utkal University, Odisha
2005
B.Sc. (Hons.)
Utkal University, Odisha
2003

Professional Memberships

Member, American Association of Pharmaceutical Scientists (AAPS) · American Chemical Society (ACS) · American Association for Cancer Research (AACR) · Indian National Young Academy of Sciences (INYAS) · INSA Distinguished Lectureship Fellow (2024)

What We Do

Research Focus Areas

Our lab pursues five interconnected research programs, combining biochemical, biophysical, and molecular biology approaches to engineer next-generation nanomedicines for the brain and beyond.

🧠

Neuro-Nanomedicine & Blood–Brain Barrier Delivery

We engineer self-assembled peptide and biomolecular nanostructures capable of traversing the blood–brain barrier for effective treatment of glioblastoma, Alzheimer's disease, brain stroke, and other CNS disorders. Our systems leverage receptor-mediated transcytosis and surface functionalization for precise brain targeting.

BBB Delivery Glioblastoma Stroke Alzheimer's
🔬

Peptide & Biomolecular Self-Assembly

We explore the fundamental self-assembly of dipeptides, amino acid derivatives, and conformationally constrained peptides into architecturally rich nanostructures — nanotubes, nanoparticles, nanorods, hydrogels, and nanobowls. These platforms are engineered for stimuli-responsive behavior and multifunctionality.

Self-Assembly Dipeptides Hydrogels Nanotubes
🎯

Cancer Nanotherapeutics

We develop targeted nanoformulations for selective delivery of chemotherapeutic agents to tumor cells, leveraging unique properties such as EPR effect, pH-responsiveness, and surface multivalency. Our systems achieve combined chemo-photothermal-photodynamic therapy with minimal off-target toxicity.

Cancer Drug Delivery PTT/PDT siRNA pH-Responsive
🌿

Neural Tissue Engineering

We design nanofibrous scaffolds and biomaterial platforms to support neuronal differentiation and neural tissue regeneration following brain or spinal cord injury. Porous 3D architectures functionalized with RGD motifs and growth factor peptides guide stem cell differentiation towards neuronal lineages.

Scaffolds Neuroregeneration 3D Cell Culture Stem Cells
⚡

Nanosensing & Diagnostics

We develop sophisticated nanosensing platforms employing SERS (Surface-Enhanced Raman Spectroscopy), electrochemical, fluorescence, and photoacoustic methods for ultra-sensitive detection of cancer biomarkers and neurodegenerative disease indicators. Our nanotheranostic agents integrate therapy with real-time diagnostics.

SERS Biosensors Fluorescence Theranostics
💡

Piezoelectric Bio-Nanomaterials

A cutting-edge emerging focus in our lab is the development of bio-piezoelectric peptide-based nanosystems that harness ultrasound or mechanical stimulation to generate electrical signals for neural modulation, amyloid disruption in Alzheimer's disease, and combinatorial electrochemotherapy in glioma.

Piezoelectric Amyloid Acoustic Neural Modulation
Research Output

Selected Publications

74+ peer-reviewed publications across high-impact journals including ACS Applied Materials & Interfaces, Nanoscale, Biomaterials Science, Small, and more.

2025 · ACS Applied Materials & Interfaces
Photoresponsive and Shape-Switchable MoS₂–Peptide-Hybrid Nanosystems for Enacting Photochemo and siRNA-Mediated Gene Therapy in Glioma
Chibh S, Aggarwal N, Gupta N, Ali S, Mishra J, et al., Panda JJ
ACS Applied Materials & Interfaces 2025 · Vol. 17(20): 29318–29340
2025 · Nanoscale
Engineering Biocompatible Hydrogen Titanate Nanocarriers with Blood Brain Barrier Crossing Potential for Doxorubicin Delivery to Glioma Cells
Choudhury S, Sahu G, Kharra P, Panda HS, Besra L, et al., Panda JJ
Nanoscale 2025 · 17(19): 12204–12219
2025 · Small
BDNF Loaded Amino Acid–Catecholamine Hybrid Nanoparticles as Curative Agents Against Cognitive Decline in Alzheimer's Disease
Panda HS, Dhokne MD, Thakur S, Singh N, Datusalia AK, Panda JJ
Small 2025 · 2411701
2024 · Biomaterials Science
Futuristic Alzheimer's Therapy: Acoustic-Stimulated Piezoelectric Nanospheres for Amyloid Reduction
Sharma M, Choudhury S, Babu A, Gupta V, Sengupta D, et al., Panda JJ
Biomaterials Science 2024 · Accepted
2023 · Nanoscale
Anti-amyloidogenic Amphipathic Arginine-Dehydrophenylalanine Spheres Capped Selenium Nanoparticles as Potent Therapeutic Moieties for Alzheimer's Disease
Kour A, Tiwari V, Aggarwal N, Sekhar Panda H, Kumar A, et al., Panda JJ
Nanoscale 2023 · 15(30): 12748–12770
2022 · ACS Applied Materials & Interfaces
Self-Fluorescent Lone Tryptophan Nanoparticles as Theranostic Agents Against Alzheimer's Disease
Sharma M, Tiwari V, Chaturvedi S, Wahajuddin M, Shukla S, Panda JJ
ACS Applied Materials & Interfaces 2022 · 14(11): 13079–13093
2021 · Bioconjugate Chemistry
Dual Blood-Brain Barrier-Glioma Targeting Peptide-Poly(levodopamine) Hybrid Nanoplatforms as Potential NIR Phototheranostic Agents in Glioblastoma
Dube T, Kumar N, Bishnoi M, Panda JJ
Bioconjugate Chemistry 2021 · 32(9): 2014–2031
Recognition

Awards & Honors

Dr. Panda's contributions have been recognized with over 30 prestigious awards and honors from national and international bodies.

🌍
International
UNESCO-L'Oréal International Fellowship for Women in Life Sciences
UNESCO · Paris, France
2011
🏅
International
ASEAN-India Women Scientists Conclave (AIWSC)
ANRF & ASTAR Singapore
2024
🧬
National
DBT Har Gobind Khorana Young Innovative Biotechnologist Award (IYBA)
Department of Biotechnology, Govt. of India
2021
🎖️
National
INSA Distinguished Lectureship Fellow
Indian National Science Academy
2024
🔬
National
ICMR-DHR International Fellowship for Biomedical Scientists
Indian Council of Medical Research
2019
👩‍🔬
National
Featured in "SHE" – 75 Best Women in STEAM
Office of the PM's Scientific Advisor & British High Commission
2022
🌱
National
Inspire Faculty Fellowship Award
Department of Science & Technology, Govt. of India
2013
🏆
National
DBT-BIOCARE Award
Department of Biotechnology, Govt. of India
2017
💊
International
AAPS Graduate Student Symposium Award, Formulation Design & Development
American Association of Pharmaceutical Scientists
2011
👁️
International
Best Free Paper Presentation Award
ASIA American Vision Research Organization
2013
🌐
International
STI Capacity Building Programme on Female Researchers
TSRI and UNCTAD
2023
⚗️
National
OPPI Young Scientist Award
Organization of Pharmaceutical Producers of India
2011
Our People

Lab Members

A vibrant, collaborative team of researchers passionate about solving the hardest problems in brain medicine and nanoscience.

JJP
Principal Investigator
Dr. Jiban Jyoti Panda
Scientist E · Institute of Nano Science and Technology, Mohali

Dr. Panda leads the NeuroNanoMed Laboratory with expertise spanning peptide chemistry, nanomedicine, and neuroscience. With a Ph.D. from ICGEB and postdoctoral experience at the University of Colorado, she has established INST as a center of excellence for brain drug delivery research in India. She is an active reviewer for Pharmaceutical Research, Journal of Ocular Pharmacology, and Therapeutic Delivery.

PostDoc

Research Scholars

Ph.D. Students
Postdoctoral Researchers
Alumni & Past Members
Grants & Support

Funding & Sponsored Research

Our research is generously supported by leading government funding agencies in India, reflecting national priority in nanomedicine and healthcare innovation.

DST-SERB
Development of Self-Assembled Peptide Nanostructures for Blood–Brain Barrier Targeted Delivery in Glioblastoma
Department of Science & Technology, Govt. of India
DBT-IYBA
Neuro-Nanotheranostic Platforms for Alzheimer's Disease: Biomolecular Nanostructures for Amyloid Targeting & Cognitive Restoration
Department of Biotechnology, Govt. of India · Har Gobind Khorana Award Grant
DST-INSPIRE
Dipeptide-Based Stimuli-Responsive Nanohydrogels for Controlled Delivery of Neural Therapeutics
Inspire Faculty Fellowship Grant · DST, Govt. of India
DBT-BIOCARE
Biomolecular Nanocarriers for Anti-Cancer Drug Delivery: Targeting Multiple Cancer Hallmarks via Peptide-Based Nanoformulations
Department of Biotechnology · DBT-BIOCARE Scheme
Latest Updates

News & Announcements

Stay up to date with publications, awards, upcoming talks, and lab activities from the NeuroNanoMed Laboratory.

🔔 Live Feed
NEW PAPER — MoS₂–Peptide nanosystems for siRNA-mediated gene therapy in glioma. ACS Appl. Mater. Interfaces, 2025
AWARD — Dr. Panda selected for ASEAN-India Women Scientists Conclave, Singapore 2024
NEW PAPER — BDNF-loaded amino acid–catecholamine nanoparticles for Alzheimer's. Small, 2025
FELLOWSHIP — INSA Distinguished Lectureship Fellow awarded, 2024
NEW PAPER — Hydrogen titanate nanocarriers for BBB-crossing doxorubicin delivery. Nanoscale, 2025
NEW PAPER — MoS₂–Peptide nanosystems for siRNA-mediated gene therapy in glioma. ACS Appl. Mater. Interfaces, 2025
AWARD — Dr. Panda selected for ASEAN-India Women Scientists Conclave, Singapore 2024
NEW PAPER — BDNF-loaded amino acid–catecholamine nanoparticles for Alzheimer's. Small, 2025
FELLOWSHIP — INSA Distinguished Lectureship Fellow awarded, 2024
NEW PAPER — Hydrogen titanate nanocarriers for BBB-crossing doxorubicin delivery. Nanoscale, 2025
12
May
2025
New Publication
Photoresponsive MoS₂–Peptide Hybrid Nanosystems Published in ACS Applied Materials & Interfaces
Our latest work on shape-switchable nanosystems for combined photochemo and siRNA gene therapy in glioma is now out. Vol. 17(20): 29318–29340.
08
Apr
2025
New Publication
Hydrogen Titanate Nanocarriers for BBB-Crossing Glioma Therapy Published in Nanoscale
Biocompatible HTiO nanocarriers with demonstrated BBB-crossing potential for targeted doxorubicin delivery published in Nanoscale, 17(19).
21
Feb
2025
New Publication
BDNF-Loaded Nanoparticles Against Cognitive Decline in Alzheimer's Disease — Published in Small
Amino acid–catecholamine hybrid nanoparticles loaded with BDNF show remarkable outcomes in reversing cognitive decline in AD models.
26
Apr
2024
Award
Dr. Panda Selected for ASEAN-India Women Scientists Conclave, Singapore
Represented India at the prestigious AIWSC organized by ANRF and ASTAR, Singapore — a recognition of her contributions to women in science and nanomedicine.
15
Mar
2024
Fellowship
Awarded INSA Distinguished Lectureship Fellowship — Indian National Science Academy
Dr. Panda has been conferred the INSA Distinguished Lectureship Fellow, recognizing her outstanding contributions to nanoscience and biotechnology research in India.
10
Jan
2024
New Publication
Futuristic Alzheimer's Therapy via Acoustic-Stimulated Piezoelectric Nanospheres — Biomaterials Science
Our paper on ultrasound-driven piezoelectric nanospheres for amyloid-β reduction in Alzheimer's disease has been accepted in Biomaterials Science.
06
Aug
2023
International Program
STI Capacity Building Programme — TSRI and UNCTAD, Thailand
Dr. Panda participated in the Bio-Circular-Green Economy Model programme for female researchers and entrepreneurs, organized by TSRI and UNCTAD (Aug 6–13, 2023).
03
Aug
2023
New Publication
Anti-Amyloidogenic Selenium Nanoparticles for Alzheimer's Disease — Nanoscale 2023
Arginine-dehydrophenylalanine capped selenium nanoparticles demonstrated potent inhibition of Aβ₄₂ aggregation in multiple in vitro models. Nanoscale, 15(30).
22
Jun
2022
National Recognition
Featured Among 75 Best Women in STEAM in India — "SHE" Book
Dr. Panda was selected as one of the best 75 women in STEAM, featured in the commemorative book "SHE" by the Office of the PM's Scientific Advisor and British High Commission to India.
15
Aug
2022
Lab Event
Lab Celebrates Independence Day — Science Outreach & Poster Presentations
Members of the NeuroNanoMed Lab participated in INST's Independence Day celebrations with science outreach activities and student poster presentations.

Announcements

Open Position NEW
PhD positions available for Jan 2026 intake. JRF/CSIR-NET holders encouraged to apply.
Posted: Dec 2025
Invited Talk NEW
Dr. Panda to deliver an invited lecture at the National Symposium on Nanomedicine, IIT Delhi, Jan 2026.
Posted: Nov 2025
Project Funding
New DST-SERB project on piezoelectric nanostructures for neural modulation funded. Positions opening soon.
Posted: Oct 2025
Summer Internship
Applications open for summer 2026 research internships (May–July). M.Sc./B.Tech students from life sciences or materials science may apply.
Posted: Oct 2025
Collaboration
Seeking collaborators for clinical translation of glioma nanotheranostics. Write to jiban@inst.ac.in.
Posted: Sep 2025
Workshop
Dr. Panda organized a national workshop on "Peptide Nanotechnology for Biomedical Applications" at INST, Sept 2025.
Posted: Sep 2025
Join Us

Open Positions

We welcome passionate, motivated researchers at all levels to join our interdisciplinary team. We are committed to scientific excellence, mentorship, and an inclusive environment.

Open

Ph.D. Research Scholars

We are looking for candidates with a strong background in chemistry, biochemistry, biotechnology, materials science, or related fields. JRF/SRF fellowship holders preferred. Admissions through INST Ph.D. program.

Apply / Enquire →
Open

Postdoctoral Fellows

Candidates with experience in nanomaterials synthesis, in vitro/in vivo biological evaluation, or biosensor development are encouraged to apply. National PDF or DST-NPDf fellowship holders are especially welcome.

Apply / Enquire →
Seasonal

Project & Intern Students

We regularly host motivated B.Tech/M.Sc./M.Tech project students and summer interns. Applications are considered on a rolling basis. Prior lab experience in synthesis or biology is a bonus but not mandatory.

Apply / Enquire →
Get In Touch

Contact Us

Reach out for collaborations, media queries, or to enquire about joining the lab.

📍
Address
Institute of Nano Science & Technology (INST)
Sector-81, Knowledge City, Sahibzada Ajit Singh Nagar,
Punjab – 140306, India
📧
🏛️
Affiliation
An Autonomous Institute Supported by the
Department of Science & Technology, Govt. of India
🔗
Online Profiles
Wikipedia  ·  Lab Site  ·  INST
🗺️
INST, Knowledge City, Mohali
Sector-81, SAS Nagar, Punjab
Near IIT Ropar highway junction
Open in Google Maps →